Malignant cancer of tonsil and base of tongue, including Hilmo

C3_TONSIL_BASEOFTONGUE_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C01&, C09 Cause of death: ICD-10 — C01&, C09 Cancer registry: Topography ICD-O-3 — C01\|C09 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	889
4. Check minimum number of events None	889
5. Include endpoints None	889
6. Filter based on genotype QC (FinnGen only)	865

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_TONSIL_BASEOFTONGUE_WIDE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C01\|C09
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C01\|C09
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C01\|C09
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant cancer of tonsil and base of tongue, including Hilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	865	259	606
Unadjusted period prevalence (%)	0.22	0.09	0.28
Median age at first event (years)	62.40	63.07	62.11

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
889: Matched controls
8890

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

UJC01

NOMESCO Finland

Scopy of lower throat

77.6

323.3

175

WF002

NOMESCO Finland

Radical radiotherapy

848.9

307.7

360

C09.0

ICD-10 Finland

Malignant neoplasm: Tonsillar fossa

+∞

307.7

314

EP1AE

NOMESCO Finland

Neck ultrasound examination

24.7

307.7

256

143

A04AA01

ATC

ondansetron; systemic, rectal

54.2

307.7

245

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

274.8

307.7

370

A03FA01

ATC

metoclopramide; systemic, rectal

27.7

307.7

557

508

H02AB02

ATC

dexamethasone; systemic

76.6

307.7

265

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

506

EMB10

NOMESCO Finland

Tonsillectomy

31.5

307.7

260

115

JDB10

NOMESCO Finland

Percutaneous gastrostomy

329.0

307.7

331

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

28.5

302.6

216

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

41.5

289.7

180

N02AA05

ATC

oxycodone; systemic

11.0

283.9

430

696

C01

ICD-10 Finland

Malignant neoplasm of base of tongue

+∞

282.9

256

8070/3-C09.9

ICD-O-3

Squamous cell carcinoma, NOS, of tonsil, NOS

+∞

280.5

254

XX3DW

NOMESCO Finland

Time consuming IT work

18.1

275.9

248

186

R4190

NOMESCO Finland

Nutritional therapy

30.3

269.7

186

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

33.0

261.2

174

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

99.3

259.4

135

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

+∞

251.3

229

C09.9

ICD-10 Finland

Malignant neoplasm: Tonsil, unspecified

+∞

239.8

219

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

37.3

231.1

147

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

54.2

218.8

126

A04AA02

ATC

granisetron; systemic, transdermal

1310.5

217.1

203

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

29.5

206.8

142

WZC00

NOMESCO Finland

Treatment plan or consultation

7.4

199.3

542

1547

GBB00

NOMESCO Finland

Tracheostomy

41.5

194.0

119

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

447.6

187.2

181

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

58.1

182.0

103

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

2108.3

177.2

166

WF003

NOMESCO Finland

Adjuvant radiotherapy

+∞

163.7

152

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

862.3

152.0

145

8070/3-C01.9

ICD-O-3

Squamous cell carcinoma, NOS, of base of tongue, NOS

+∞

150.4

140

C09.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of tonsil

+∞

139.3

130

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

139.3

130

EBA15

NOMESCO Finland

Extraction of multiple teeth

10.3

129.8

158

182

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

484.6

129.5

126

UDQ12

NOMESCO Finland

Flexible laryngoscopy

8.7

129.4

184

258

ZX090

NOMESCO Finland

Other technic of radiotherapy

295.8

127.7

127

A07AA02

ATC

nystatin; oral

9.4

124.0

163

207

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

10.1

116.4

143

166

EMA10

NOMESCO Finland

Biopsy of tonsil

1226.1

113.2

108

Z51.5

ICD-10 Finland

Palliative care

11.2

113.1

127

130

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

113.0

106

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

+∞

108.6

102

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

585.1

107.1

104

JN4BD

NOMESCO Finland

Extensive body CT

8.5

102.0

144

198

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

99.9

WW500

NOMESCO Finland

Blood transfusion

16.7

98.6

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

8.6

98.0

136

183

WX408

NOMESCO Finland

General anesthesy, balanced

4.4

98.0

368

1234

WZC30

NOMESCO Finland

Teaching

5.2

97.7

248

611

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

34.4

95.2

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

352.9

94.9

SAA03

NOMESCO Finland

Extended examination of mouth

4.1

94.0

509

2196

D10.4

ICD-10 Finland

Benign neoplasm: Tonsil

179.1

93.2

UDH02

NOMESCO Finland

Rhinopharyngoscopy

6.3

87.1

164

306

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

128.1

86.8

JN6AD

NOMESCO Finland

CT of torso and neck

40.2

86.4

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

3.9

85.3

533

2485

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

+∞

84.8

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

6.1

84.7

168

329

ZX070

NOMESCO Finland

Intensity modified radiotherapy

888.3

84.0

R13

ICD-10 Finland

Dysphagia

6.0

83.1

167

331

A04AD12

ATC

aprepitant; systemic

+∞

81.5

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

297.2

81.0

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

12.1

79.9

A04AA55

ATC

palonosetron, combinations; systemic

+∞

79.4

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

42.2

79.3

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

103.0

77.4

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

44.0

76.7

UJC02

NOMESCO Finland

Rigid oesophagoscopy

30.0

76.4

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

4.5

76.2

230

641

ENA10

NOMESCO Finland

Biopsy of pharynx

276.6

75.7

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

201.5

72.3

WX402

NOMESCO Finland

General anaesthesia

4.0

72.2

274

899

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

163.6

72.2

EBA10

NOMESCO Finland

Operative extraction of tooth

4.9

71.9

183

444

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

8.0

70.0

101

141

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

5.4

69.3

154

332

9680/3-C09.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of tonsil, NOS

+∞

67.6

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

+∞

67.6

L03AA13

ATC

pegfilgrastim; parenteral

241.2

66.2

D37.08

ICD-10 Finland

Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx

126.5

65.9

L03AA02

ATC

filgrastim; parenteral

180.9

64.9

JCW98

NOMESCO Finland

Other transluminal endoscopic procedure on oesophagus

+∞

64.4

8070/3-C09.0

ICD-O-3

Squamous cell carcinoma, NOS, of tonsillar fossa

+∞

62.2

C61

ICD-10 Finland

Malignant neoplasm of prostate

640.5

61.5

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

8.7

58.0

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

58.0

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

160.6

57.6

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

56.9

SBB10

NOMESCO Finland

Dental impressions

5.8

56.3

112

217

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

6.8

54.5

145

WF049

NOMESCO Finland

Radiotherapy of metastasis

560.6

54.1

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

287.9

53.8

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

549.3

53.1

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

6.0

52.3

179

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

13.2

51.6

J35.1

ICD-10 Finland

Hypertrophy of tonsils

16.5

51.5

SCA02

NOMESCO Finland

Preventive oral health care

4.5

50.0

136

343

EJB20

NOMESCO Finland

Excision of tumor or other lesion of base of tongue

264.5

49.6

A06AD11

ATC

lactulose; oral

3.5

49.2

209

721

ZX120

NOMESCO Finland

Intravenous

4.8

49.2

123

290

H03AA01

ATC

levothyroxine sodium; systemic

3.1

47.1

254

1010

PJD51

NOMESCO Finland

Block dissection of cervical lymph nodes

+∞

46.2

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

16.1

46.2

R4130

NOMESCO Finland

Speech therapy

7.4

44.2

SXC03

NOMESCO Finland

Other oral or dental procedure

13.3

43.7

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

154.1

42.2

UDQ22

NOMESCO Finland

Microlaryngoscopy

14.7

41.8

TJD20

NOMESCO Finland

Change of gastrostomy tube

115.6

41.1

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

40.9

JN4AD

NOMESCO Finland

Body CT examination

4.5

40.8

107

261

UGC12

NOMESCO Finland

Flexible bronchoscopy

4.1

40.1

122

333

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

40.1

505

3035

K11.70

ICD-10 Finland

Hypoptyalism

67.6

39.5

XW000

NOMESCO Finland

Bone marrow biopsy

6.6

38.6

103

GD1AD

NOMESCO Finland

Thorax CT examination

4.6

38.3

230

R07.0

ICD-10 Finland

Pain in throat

4.6

37.3

222

WF004

NOMESCO Finland

Palliative radiotherapy

+∞

36.7

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

36.7

SBA00

NOMESCO Finland

Microbiological examinations

8.7

36.2

EBB10

NOMESCO Finland

Insertion of dental implant

11.0

36.0

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

8.4

35.3

ENB20

NOMESCO Finland

Pharyngectomy

360.9

35.2

ZXE30

NOMESCO Finland

More than five and less than seven hours

5.3

34.2

142

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

7.0

33.9

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

33.5

9591/3-C09.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of tonsil, NOS

+∞

33.5

WX002

NOMESCO Finland

Sedation and analgesia

2.7

33.5

239

1081

SCA03

NOMESCO Finland

Preventive oral health care, extensive

5.4

33.5

137

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

11.0

33.3

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.8

33.0

197

813

K04.5

ICD-10 Finland

Chronic apical periodontitis

2.4

32.6

324

1709

116

Kela drug reimbursment

Prostate cancer

+∞

32.5

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

12.8

31.6

TPX10

NOMESCO Finland

Implantation of vascular injection port

7.7

31.6

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

31.4

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

+∞

31.4

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

323.8

31.0

K05.31

ICD-10 Finland

Periodontitis pronounced

2.9

30.8

168

658

D70.82

ICD-10 Finland

Drug-induced neutropenia

53.5

30.5

RD210, ,

NOMESCO Finland

9.4

30.5

TPH07

NOMESCO Finland

Cathetrisation of artery

3.2

30.4

139

493

SAA04

NOMESCO Finland

Special examination of mouth

4.3

29.8

202

Z3226

NOMESCO Finland

Physiotherapist

2.7

29.8

203

892

SCA04

NOMESCO Finland

Guidance on care of mouth and oral mucosa

51.9

29.6

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

7.5

29.5

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

29.3

B01AB10

ATC

tinzaparin; parenteral

3.6

29.3

103

309

R4110

NOMESCO Finland

Physiotherapy

2.4

29.2

283

1464

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

35.0

28.9

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.6

28.6

213

976

115

Kela drug reimbursment

Breast cancer

+∞

28.3

WX110

NOMESCO Finland

Infiltration anesthesia

2.3

28.2

645

4708

QA1S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in head

34.0

28.0

ZXE00

NOMESCO Finland

One hour or less

2.2

28.0

366

2138

ENB00

NOMESCO Finland

Excision or exploration of lesion of pharynx

290.2

27.9

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

29.6

27.8

ZXE40

NOMESCO Finland

More than seven and less than nine hours

7.4

27.7

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

+∞

27.2

A02BC05

ATC

esomeprazole; systemic

2.1

26.8

415

2577

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

4.6

26.4

150

ED1AA

NOMESCO Finland

Mandibular X-ray examination

38.0

26.3

C02.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of tongue

+∞

26.2

PJA12

NOMESCO Finland

Sentinel node biopsy

268.0

25.8

D10.10

ICD-10 Finland

Benign tumor at the base of the tongue

96.3

25.8

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

5.8

25.6

K10.26

ICD-10 Finland

Periostitis of jaw (acute)(chronic)(suppurative)

+∞

25.1

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

25.1

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

25.1

ZZA00

NOMESCO Finland

Split skin graft

6.3

24.7

Z2221

NOMESCO Finland

Medical doctor

2.3

24.5

256

1351

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

5.6

24.5

K08.3

ICD-10 Finland

Retained dental root

3.1

24.4

113

402

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

3.3

24.2

311

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

24.1

303

1720

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

24.1

Z2446

NOMESCO Finland

Social worker

3.7

24.0

231

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.9

23.9

126

481

EMB00

NOMESCO Finland

Excision of lesion of tonsil or adenoids

69.4

23.9

ZXD10

NOMESCO Finland

Scheduled procedure

2.1

23.8

356

2157

Z43.1

ICD-10 Finland

Attention to gastrostomy

246.4

23.8

J02AC01

ATC

fluconazole; systemic

2.1

23.6

305

1749

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

23.1

225

1150

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

235.8

22.7

EBB15

NOMESCO Finland

Insertion of dental implant abutment

21.4

22.7

ZXE20

NOMESCO Finland

More than three and less than five hours

2.6

22.0

145

620

ECB20

NOMESCO Finland

Oral alveoplasty

8.7

22.0

C09.1

ICD-10 Finland

Malignant neoplasm: Tonsillar pillar (anterior)(posterior)

+∞

22.0

UJC20

NOMESCO Finland

Extensive endoscopy to identify diagnosed or suspected primary malignant neoplasm of head or neck

+∞

22.0

T05

ICPC

Feeding problem of adult

20.7

21.8

ZXE10

NOMESCO Finland

More than one and less than three hours

2.0

21.4

329

1996

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

9.2

21.3

8085/3-C01.9

ICD-O-3

Squamous cell carcinoma, HPV positive of base of tongue, NOS

+∞

20.9

EDB00

NOMESCO Finland

Partial excision of mandible

+∞

20.9

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

20.9

RD160, ,

NOMESCO Finland

78.7

20.8

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

214.8

20.7

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

3.7

20.6

190

SXA10

NOMESCO Finland

Oral mucosal sampling

8.4

20.6

A02BC02

ATC

pantoprazole; systemic

2.0

20.2

617

4702

ENB40

NOMESCO Finland

Excision of branchial cyst or fistula

58.9

20.0

K05.30

ICD-10 Finland

Periodontitis complex

2.3

20.0

172

830

WX302

NOMESCO Finland

Thoracal epidural anesthesy

5.3

19.9

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

+∞

19.9

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

19.9

9673/3-C09.9

ICD-O-3

Mantle cell lymphoma of tonsil, NOS

+∞

19.9

Z3231

NOMESCO Finland

Registered nurse

2.1

19.8

251

1412

D37.09

ICD-10 Finland

Lip, oral cavity and pharynx

107.5

19.6

WX707

NOMESCO Finland

Fiberoscopic intubation

47.1

19.3

JN4CD

NOMESCO Finland

Very extensive body CT

7.4

19.2

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

4.1

19.0

139

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

8.3

18.8

L01BC06

ATC

capecitabine; oral

+∞

18.8

C09

ICD-10 Finland

Malignant neoplasm of tonsil

+∞

18.8

Z51.0

ICD-10 Finland

Radiotherapy session

+∞

18.8

C02.4

ICD-10 Finland

Malignant neoplasm: Lingual tonsil

+∞

18.8

EJB40

NOMESCO Finland

Hemiglossectomy

+∞

18.8

ENB99

NOMESCO Finland

Other excision of pharynx and adjacent structures

71.5

18.8

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

7.8

18.8

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.6

18.7

117

486

EP1CM

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with 3 Tesla magnet

193.9

18.6

UJC12

NOMESCO Finland

Flexible oesophagoscopy

15.5

18.5

Q18.0

ICD-10 Finland

Sinus, fistula and cyst of branchial cleft

30.8

18.4

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

5.0

18.4

PJA10

NOMESCO Finland

Exploration of lymph nodes

18.0

18.3

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.6

18.2

112

462

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

27.3

17.9

C04.0

ICD-10 Finland

Malignant neoplasm: Anterior floor of mouth

+∞

17.8

EJB30

NOMESCO Finland

Excision of tumor or other lesion of floor of the mouth

+∞

17.8

8085/3-C09.9

ICD-O-3

Squamous cell carcinoma, HPV positive of tonsil, NOS

+∞

17.8

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

17.8

EBA12

NOMESCO Finland

Demanding operative extraction of tooth

5.6

17.7

EP1BG

NOMESCO Finland

MRI examination of soft tissue of neck with high intesity magnet

37.5

17.7

EB1WA, ,

NOMESCO Finland

13.5

17.5

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

6.9

17.5

EBA00

NOMESCO Finland

Extraction of tooth

1.9

17.4

341

2213

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

32.2

17.1

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

26.2

17.0

B01AB05

ATC

enoxaparin; parenteral

1.9

16.9

265

1596

C02.10

ICD-10 Finland

Malignant neoplasm of tip of tongue

+∞

16.7

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

16.7

C02.9

ICD-10 Finland

Malignant neoplasm: Tongue, unspecified

+∞

16.7

PJD91

NOMESCO Finland

Excision of lymph nodes in neck, 1 to 2 areas in total

+∞

16.7

HAC20

NOMESCO Finland

Total mastectomy

173.1

16.5

K13.78

ICD-10 Finland

Other change in the oral mucosa

5.3

16.4

ZXC96

NOMESCO Finland

Robot assisted procedure

17.1

16.1

K02.1

ICD-10 Finland

Caries of dentine

1.8

15.9

510

3809

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

15.7

250

1508

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

15.7

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

15.7

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

+∞

15.7

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

15.7

R21

ICPC

Throat symptom/complaint

2.2

15.6

153

773

D77

ICPC

Malignant digestive neopl other/NOS

162.8

15.5

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

162.8

15.5

L02AE02

ATC

leuprorelin; implant, parenteral

38.8

15.4

212

Kela drug reimbursment

Gout

5.1

15.3

TQW99

NOMESCO Finland

Other minor procedure on skin

3.7

15.3

142

EBB11

NOMESCO Finland

Insertion of additional dental implant in one session

18.1

15.2

K12.10

ICD-10 Finland

Stomatitis NOS

23.9

15.2

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

32.3

14.8

EDW99

NOMESCO Finland

Other operation on mandible

32.3

14.8

EJB10

NOMESCO Finland

Excision of tumor or other lesion of apex or body of tongue

32.3

14.8

UDQ02

NOMESCO Finland

Direct laryngoscopy

11.6

14.8

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

2.2

14.8

136

670

N05CF01

ATC

zopiclone; oral

1.8

14.7

293

1889

SDA03

NOMESCO Finland

Periodontal treatment

1.8

14.7

342

2310

8070/3-C02.9

ICD-O-3

Squamous cell carcinoma, NOS, of tongue, NOS

+∞

14.6

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

14.6

C10.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of oropharynx

+∞

14.6

8070/3-C02.1

ICD-O-3

Squamous cell carcinoma, NOS, of border of tongue

+∞

14.6

WW300

NOMESCO Finland

Transfer of autologic stem cells

+∞

14.6

SXC05

NOMESCO Finland

Other oral or dental procedure

3.0

14.5

231

A79

ICPC

Malignancy NOS

152.4

14.5

D10.9

ICD-10 Finland

Benign neoplasm: Pharynx, unspecified

152.4

14.5

SPA60

NOMESCO Finland

Fitting of intermediary dental prosthesis structures, 1 to 3 units

5.0

14.3

ZXB10

NOMESCO Finland

Medial

17.3

14.3

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

43.2

14.1

R50.9

ICD-10 Finland

Fever, unspecified

2.2

14.1

136

682

K08.2

ICD-10 Finland

Atrophy of edentulous alveolar ridge

6.1

13.9

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

6.1

13.9

SPA20

NOMESCO Finland

Selection and insertion of implant abutment

24.2

13.8

XQ902

NOMESCO Finland

Other photography

15.0

13.6

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

4.8

13.6

C32.9

ICD-10 Finland

Malignant neoplasm: Larynx, unspecified

+∞

13.6

C03.1

ICD-10 Finland

Malignant neoplasm: Lower gum

+∞

13.6

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

13.6

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

11.1

13.6

R85

ICPC

Malignant neopl respiratory other

142.1

13.5

WX199

NOMESCO Finland

Other local analgesia

3.5

13.5

135

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

21.5

13.4

D10.5

ICD-10 Finland

Benign neoplasm: Other parts of oropharynx

40.7

13.2

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.7

13.0

293

JN4DR

NOMESCO Finland

Whole body metabolic PET with CT

70.9

12.6

QA7S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in jaw or lips

70.9

12.6

D10.19

ICD-10 Finland

Benign tumor of the tongue UNS

17.6

12.5

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

12.5

C10.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of oropharynx

+∞

12.5

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

12.5

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

12.5

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

12.5

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

+∞

12.5

GD6AD

NOMESCO Finland

CT of chest and neck

24.7

12.5

ZX050

NOMESCO Finland

Stereotactic radiotherapy

131.8

12.5

C90.0

ICD-10 Finland

Multiple myeloma

131.8

12.5

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.9

12.3

219

TJW99

NOMESCO Finland

Other minor procedure in gastrointestinal endoscopy

38.1

12.2

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

2.6

12.2

314

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.7

12.2

293

1975

XX1XW

NOMESCO Finland

Extensive written report from radiologist

4.7

12.2

K13.29

ICD-10 Finland

Indefinite leukoplakia

6.1

12.2

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

21.6

12.0

J01DB01

ATC

cefalexin; oral

1.8

12.0

712

6090

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

11.9

466

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

30.5

11.7

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

65.8

11.6

L02BA01

ATC

tamoxifen; oral

65.8

11.6

EWE00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of teeth, jaws, mouth and pharynx

65.8

11.6

ZZR00

NOMESCO Finland

Flap of skin

19.2

11.6

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

3.7

11.6

ZXA00

NOMESCO Finland

Right side

1.7

11.5

242

1568

C10.0

ICD-10 Finland

Malignant neoplasm: Vallecula

+∞

11.5

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

11.5

C50.99

ICD-10 Finland

Breast, unspecified

+∞

11.5

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

11.5

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

11.5

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

11.5

XX1AD

NOMESCO Finland

Other CT-examination

121.5

11.4

EP1DM

NOMESCO Finland

Very extensive MRI examination of soft tissue of neck with 3 Tesla magnet

121.5

11.4

M04AA01

ATC

allopurinol; systemic

2.0

11.3

143

789

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

10.7

11.3

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

9.1

11.3

EHA10

NOMESCO Finland

Biopsy of palate

12.9

11.2

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.2

11.2

472

D38.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Larynx

20.3

11.2

SPA02

NOMESCO Finland

Preparation for dental prosthetics

3.3

11.1

127

SCA01

NOMESCO Finland

Preventive oral health care, short

1.8

11.1

217

1376

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

4.5

11.0

J01CE02

ATC

phenoxymethylpenicillin; oral

1.6

11.0

574

4672

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.9

11.0

181

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

10.8

111

569

K02.2

ICD-10 Finland

Caries of cementum

2.7

10.8

229

ZXC10

NOMESCO Finland

Use of laser

3.9

10.7

SBB20

NOMESCO Finland

Tooth X-ray examination in conjunction with visit to dentist

5.4

10.6

D21

ICPC

Swallowing problem

4.6

10.5

K02.9

ICD-10 Finland

Dental caries, unspecified

4.9

10.5

AA1BD

NOMESCO Finland

Extensive CT of head and brain

4.9

10.5

J01MA12

ATC

levofloxacin; systemic

1.8

10.5

164

970

K02.0

ICD-10 Finland

Caries limited to enamel

2.0

10.4

129

706

Y77

ICPC

Malignant neoplasm prostate

111.3

10.4

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

10.4

C04.1

ICD-10 Finland

Malignant neoplasm: Lateral floor of mouth

+∞

10.4

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

+∞

10.4

JN5AP

NOMESCO Finland

Total body PET (1 picture)

+∞

10.4

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

10.4

C05.1

ICD-10 Finland

Malignant neoplasm: Soft palate

+∞

10.4

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

10.4

C13.9

ICD-10 Finland

Malignant neoplasm: Hypopharynx, unspecified

+∞

10.4

C10.9

ICD-10 Finland

Malignant neoplasm: Oropharynx, unspecified

+∞

10.4

ZXA05

NOMESCO Finland

Left side

1.7

10.4

220

1422

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.3

10.4

358

1XC02, ,

NOMESCO Finland

16.3

10.4

ZXA10

NOMESCO Finland

Bilateral

1.8

10.3

162

960

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.6

10.3

KCD02

NOMESCO Finland

Transurethral resection of bladder

23.7

10.3

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

10.2

227

1486

HA1AA

NOMESCO Finland

X-ray mammography

4.2

10.2

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

13.3

10.2

A06AH03

ATC

naloxegol; oral

13.3

10.2

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.2

10.1

449

R11

ICD-10 Finland

Nausea and vomiting

2.4

10.1

311

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.7

10.1

213

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

9.3

10.0

ZX112

NOMESCO Finland

Subcutaneous

10.2

10.0

L02BG04

ATC

letrozole; oral

14.8

10.0

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

26.3

9.8

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

8.9

9.8

SPC10

NOMESCO Finland

Standard dental crown

4.3

9.7

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

3.4

9.7

107

JDB00

NOMESCO Finland

Gastrostomy

55.6

9.7

K11.2

ICD-10 Finland

Sialoadenitis

3.1

9.6

128

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.9

9.5

167

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.6

9.5

214

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

101.1

9.4

Z93.1

ICD-10 Finland

Gastrostomy status

101.1

9.4

QAB05

NOMESCO Finland

Revision of wound of skin of head or neck

30.4

9.4

1460A

ICD-9 Finland

Malignant neoplasm of oropharynx, Tonsil

+∞

9.4

GB3AV, ,

NOMESCO Finland

+∞

9.4

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

9.4

C32.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of larynx

+∞

9.4

C13.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of hypopharynx

+∞

9.4

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

+∞

9.4

EJB60

NOMESCO Finland

Partial excision of floor of mouth

+∞

9.4

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

9.4

401

SBA10

NOMESCO Finland

Measurement of salivary flow rate

7.0

9.4

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

7.4

9.3

DQA10

NOMESCO Finland

Biopsy of larynx

13.8

9.2

J36

ICD-10 Finland

Peritonsillar abscess

3.6

9.1

Z01.2

ICD-10 Finland

Dental examination

1.6

9.1

349

2601

ECA20

NOMESCO Finland

Biopsy of gingiva

8.4

9.1

JDB01

NOMESCO Finland

Laparoscopic gastrostomy

37.1

9.0

J35.9

ICD-10 Finland

Chronic disease of tonsils and adenoids, unspecified

37.1

9.0

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

18.8

8.9

EDA10

NOMESCO Finland

Biopsy of mandible

24.3

8.9

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

24.3

8.9

D14.1

ICD-10 Finland

Benign neoplasm: Larynx

12.7

8.9

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

3.2

8.9

113

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

5.0

8.9

EP1AE, ,

SPAT

4.7

8.9

L57.0

ICD-10 Finland

Actinic keratosis

2.2

8.8

343

B37.08

ICD-10 Finland

Other candidal stomatitis

9.6

8.8

UGC02

NOMESCO Finland

Rigid bronchoscopy

50.5

8.7

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

50.5

8.7

ZXD05

NOMESCO Finland

Urgent procedure

1.6

8.7

246

1706

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

8.6

522

4284

R68.2

ICD-10 Finland

Dry mouth, unspecified

16.5

8.6

ZZF00

NOMESCO Finland

Graft of adipose tissue

16.5

8.6

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

20.2

8.5

S04

ICPC

Lump/swelling localized

2.1

8.5

424

A01AB10

ATC

natamycin; local oral

3.6

8.5

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

90.9

8.4

SPD01

NOMESCO Finland

Mucosa-supported complete denture

4.7

8.4

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

8.3

483

A01AB09

ATC

miconazole; local oral

2.2

8.3

351

QA9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in head or neck, unspecified

+∞

8.3

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

8.3

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

8.3

C02.0

ICD-10 Finland

Malignant neoplasm: Dorsal surface of tongue

+∞

8.3

C04.9

ICD-10 Finland

Malignant neoplasm: Floor of mouth, unspecified

+∞

8.3

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

8.3

9691/3-C09.9

ICD-O-3

Follicular lymphoma, grade 2 of tonsil, NOS

+∞

8.3

4707

FHL

Dissection Colli radicalis

+∞

8.3

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

8.3

Z85.7

ICD-10 Finland

Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues

+∞

8.3

C02.1

ICD-10 Finland

Malignant neoplasm: Border of tongue

+∞

8.3

8070/3-C04.9

ICD-O-3

Squamous cell carcinoma, NOS, of floor of mouth, NOS

+∞

8.3

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

8.3

SPC20

NOMESCO Finland

Implant borne crown

10.9

8.3

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

9.6

8.3

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.9

8.3

140

TJD10

NOMESCO Finland

Insertion of other tube into stomach or duodenum

33.7

8.1

J39.2

ICD-10 Finland

Other diseases of pharynx

7.3

8.0

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

8.0

447

3585

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

2.6

7.9

178

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

7.9

157

991

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

2.9

7.9

127

N02BE01

ATC

paracetamol; systemic, rectal

1.7

7.9

757

6823

A41.9

ICD-10 Finland

Sepsis, unspecified

2.9

7.8

122

UDQ42

NOMESCO Finland

Endoscopic assessment of swallowing function

10.9

7.8

B37.0

ICD-10 Finland

Candidal stomatitis

6.4

7.7

D10.7

ICD-10 Finland

Benign neoplasm: Hypopharynx

45.4

7.7

WZC15, ,

NOMESCO Finland

45.4

7.7

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

18.5

7.6

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

7.6

410

3251

XX3ZW, ,

NOMESCO Finland

25.2

7.6

SCB02

NOMESCO Finland

Instructions for self-performed oral hygiene

25.2

7.6

ZZR30

NOMESCO Finland

Flap of muscle

25.2

7.6

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

7.4

206

1414

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

80.7

7.4

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

80.7

7.4

C32.1

ICD-10 Finland

Malignant neoplasm: Supraglottis

80.7

7.4

GBB13

NOMESCO Finland

Revision of tracheostomy

80.7

7.4

EDC38

NOMESCO Finland

Open reduction and fixation of fracture of body of mandible

13.5

7.4

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

7.3

189

1275

XX2RW, ,

NOMESCO Finland

11.0

7.3

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

11.0

7.3

K03.66

ICD-10 Finland

Tooth plaque

2.1

7.3

315

UDC00

NOMESCO Finland

Ear microscopy

2.1

7.3

363

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

7.3

C06.0

ICD-10 Finland

Malignant neoplasm: Cheek mucosa

+∞

7.3

8083/3-C09.9

ICD-O-3

Basaloid squamous cell carcinoma of tonsil, NOS

+∞

7.3

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

+∞

7.3

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

7.3

9680/3-C01.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of base of tongue, NOS

+∞

7.3

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

7.3

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

7.3

QAE30

NOMESCO Finland

Excision and repair of surgical scar in head or neck

+∞

7.3

EJC99

NOMESCO Finland

Other reconstructive operations on tongue and floor of mouth

+∞

7.3

EP1KS

NOMESCO Finland

Very extensive PET-MRI of neck metabolism

+∞

7.3

C11.9

ICD-10 Finland

Malignant neoplasm: Nasopharynx, unspecified

+∞

7.3

9823/3-C09.9

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of tonsil, NOS

+∞

7.3

2008X

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Other named variants

+∞

7.3

L02BB03

ATC

bicalutamide; oral

+∞

7.3

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

+∞

7.3

C02.2

ICD-10 Finland

Malignant neoplasm: Ventral surface of tongue

+∞

7.3

DQE00

NOMESCO Finland

Implantation of prosthetic replacement for larynx

+∞

7.3

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

7.3

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

7.3

Z50.5

ICD-10 Finland

Speech therapy

5.9

7.2

D28

ICPC

Limited function/disability (D)

30.3

7.2

E03.89

ICD-10 Finland

Other specified hypothyroidism

3.1

7.1

N02AA01

ATC

morphine; systemic, rectal

5.7

7.1

SPE02

NOMESCO Finland

Metal-framed partial denture

3.4

7.0

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

7.0

234

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

6.9

353

2753

J01FF01

ATC

clindamycin; systemic

1.5

6.9

226

1609

R04.1

ICD-10 Finland

Haemorrhage from throat

13.9

6.9

ECA30

NOMESCO Finland

Excision of lesion of gingiva

6.8

SPF20

NOMESCO Finland

Temporary relining of dentures

6.8

ZXX06

NOMESCO Finland

Extent of procedure, 6 units

40.4

6.8

DWD00

NOMESCO Finland

Reoperation for superficial heamorrhage in surgery of ear, nose and larynx

40.4

6.8

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

40.4

6.8

PA6YT

NOMESCO Finland

Dilatation of carotid artery with stent

16.8

6.8

K03.28

ICD-10 Finland

Other erosion of teeth

3.4

6.7

NK6AN

NOMESCO Finland

Total body bone isotope imaging

22.7

6.7

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

22.7

6.7

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

6.5

6.7

K00.09

ICD-10 Finland

Lack of teeth due to lack of dental development UNS

4.1

6.6

N05BA06

ATC

lorazepam; systemic, sublingual

2.4

6.6

201

SPF30

NOMESCO Finland

Relining of denture

3.5

6.6

SPD05

NOMESCO Finland

Mucosa borne complete denture, demanding

12.4

6.6

ECB15

NOMESCO Finland

Plastic repair of oronasal or oroantral fistula

8.8

6.6

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

10.1

6.5

K12.18

ICD-10 Finland

Other forms of stomatitis

10.1

6.5

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.5

6.5

159

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

5.4

6.5

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

5.8

6.5

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

4.0

6.5

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

70.3

6.4

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

70.3

6.4

JDA08

NOMESCO Finland

Endoscopic removal of foreign body from stomach or pylorus

70.3

6.4

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

3.0

6.4

RS316, ,

NOMESCO Finland

14.4

6.4

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

14.4

6.4

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.1

6.4

277

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

8.2

6.3

K92.0

ICD-10 Finland

Haematemesis

3.0

6.3

K10.25

ICD-10 Finland

Sequences of jawbones

9.3

6.3

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

6.3

568

4895

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

6.3

WW402

NOMESCO Finland

Leucoferesis

+∞

6.3

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

6.3

GBB18

NOMESCO Finland

Closure of tracheostomy

+∞

6.3

JAA96

NOMESCO Finland

Other local operation on abdominal wall

+∞

6.3

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

6.3

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

6.3

8072/3-C09.9

ICD-O-3

Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of tonsil, NOS

+∞

6.3

C15.9

ICD-10 Finland

Malignant neoplasm: Oesophagus, unspecified

+∞

6.3

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

6.3

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

6.3

KAC10

NOMESCO Finland

Total nephrectomy with capsule

+∞

6.3

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

6.3

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

6.3

8085/3-C09.0

ICD-O-3

Squamous cell carcinoma, HPV positive of tonsillar fossa

+∞

6.3

B72

ICPC

Hodgkin Lymphoma

+∞

6.3

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

6.3

EL3AN

NOMESCO Finland

Isotope imaging of salivary glands

+∞

6.3

C01BD, ,

ICD-10 Finland

+∞

6.3

JN6CD

NOMESCO Finland

Very extensive CT of torso and neck

+∞

6.3

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

6.3

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

+∞

6.3

2000B

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]

+∞

6.3

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

6.3

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

6.3

H02AB06

ATC

prednisolone; systemic

1.4

6.2

382

3070

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

6.2

131

839

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

6.3

6.2

SPA47

NOMESCO Finland

Precision impression for denture

2.7

6.1

122

B01AB04

ATC

dalteparin; parenteral

2.6

6.1

134

HAB40

NOMESCO Finland

Wedge excision of mammary gland

12.6

6.1

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.3

6.1

196

SPF10

NOMESCO Finland

Demanding reparation of dental prosthesis

3.4

6.0

XX1VW

NOMESCO Finland

Written report from radiologist

6.1

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(4035726) Immunohistochemistry procedure

417

199

38.58

307.65

1.5

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

186

28.77

264.62

1.3

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

452

1056

7.67

205.23

7.2

2.8

0.77

0.83

mmol/l

22.84

444

983

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

193

185

13.05

182.37

3.5

2.6

1.13

1.57

mg/l

8.86

193

164

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

301

550

7.76

169.92

2.8

2.0

0.24

0.21

g/l

9.67

293

496

(40768804) Tissue Pathology biopsy report

573

2021

6.16

157.80

2.8

1.6

—

(40768795) Lymph node Pathology biopsy report

39.13

100.36

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

482

2034

3.99

91.25

6.1

2.1

2.37

2.35

mmol/l

2.92

454

1683

(3013650) Neutrophils [#/volume] in Blood by Automated count

685

3738

4.63

87.90

14.1

6.6

4.02

4.31

e9/l

2.84

620

3251

(3002256) Pathology report gross observation

199

479

5.06

79.38

1.4

1.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

614

3363

3.67

72.04

9.7

4.0

10.23

12.53

umol/l

6.27

603

3170

(3024561) Albumin [Mass/volume] in Serum or Plasma

535

2826

3.24

63.77

6.6

3.9

35.07

35.78

g/l

1.99

510

2604

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

114.80

59.68

1.1

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

539

2951

3.10

58.60

3.1

2.3

—

(3044640) Blood type and Crossmatch panel - Blood

408

1921

3.08

58.06

3.1

2.1

—

(40758558) Short blood count panel - Blood

342

1585

2.88

48.24

10.8

4.9

—

(3022096) Basophils/100 leukocytes in Blood

520

3036

2.72

45.97

6.7

5.9

0.63

0.69

1.81

491

2813

(3006504) Eosinophils/100 leukocytes in Blood

529

3146

2.68

44.54

6.9

5.8

2.69

3.05

2.98

500

2925

(40760892) CBC W Ordered Manual Differential panel - Blood

529

3155

2.67

44.13

7.6

5.9

—

(3001604) Monocytes [#/volume] in Blood

550

3368

2.66

43.06

6.7

5.6

0.62

0.61

e9/l

0.18

481

2926

(3019069) Monocytes/100 leukocytes in Blood

526

3161

2.63

42.68

7.3

6.2

9.48

8.88

3.03

500

2936

(3033658) Prothrombin time (PT) actual/Normal

338

1642

2.71

42.52

5.1

3.6

88.41

85.90

1.08

333

1599

(3006315) Basophils [#/volume] in Blood

550

3382

2.64

42.46

6.7

5.6

0.04

e9/l

2.55

480

2940

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

319

1515

2.72

41.86

2.8

2.1

—

(3002030) Lymphocytes/100 leukocytes in Blood

529

3226

2.58

41.01

7.1

5.9

23.44

27.35

11.44

503

3015

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

737

5311

3.27

40.91

12.0

5.5

79.47

75.23

u/l

2.01

717

4936

(3013115) Eosinophils [#/volume] in Blood

559

3509

2.60

40.60

7.0

5.8

0.18

0.21

e9/l

4.54

495

3095

(3019198) Lymphocytes [#/volume] in Blood

553

3458

2.59

40.42

6.8

5.7

1.68

1.85

e9/l

0.65

492

3071

(3023368) Bacteria identified in Blood by Culture

362

1877

2.57

39.19

5.8

4.1

—

(3018010) Neutrophils/100 leukocytes in Blood

521

3198

2.52

39.16

6.8

5.8

60.50

57.41

6.58

494

2987

(3026389) Candida sp identified in Specimen by Organism specific culture

8.22

39.09

1.4

1.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

536

3342

2.52

38.80

8.8

6.0

1.21

mmol/l

0.15

451

2870

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

117

325

3.99

37.47

3.5

1.4

22.52

2.71

ug/l

0.88

243

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

257

1158

2.72

36.70

5.3

2.0

2.49

2.44

mmol/l

6.97

238

973

(3003458) Phosphate [Moles/volume] in Serum or Plasma

216

906

2.83

35.28

5.9

5.8

0.97

1.02

mmol/l

2.48

205

833

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

491

3064

2.35

33.70

8.0

5.5

1.21

mmol/l

0.01

461

2741

(3007853) Bacteria identified in Skin by Aerobe culture

192

807

2.76

30.86

2.0

1.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

523

3438

2.27

30.58

14.7

16.5

1.22

1.34

inr

2.46

159

969

(3021879) Hepatitis B virus core Ab [Presence] in Serum

115

363

3.49

30.34

1.3

1.5

—

(3003694) ABO and Rh group [Type] in Blood

319

1716

2.34

30.22

1.4

1.3

—

(3018418) pH of Serum or Plasma

336

1896

2.24

27.96

5.3

3.3

7.40

0.05

311

(3013826) Glucose [Moles/volume] in Serum or Plasma

592

4218

2.21

26.71

6.8

4.6

6.46

6.82

mmol/l

4.68

571

3949

(3021589) Normoblasts [#/volume] in Blood

457

2996

2.08

25.04

13.0

8.5

0.00

e9/l

0.34

380

2466

(3035637) Corticotropin [Mass/volume] in Plasma

7.10

21.76

1.5

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

155

689

2.51

21.70

3.2

2.3

7.11

8.60

umol/l

0.45

142

606

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

178

849

2.37

21.32

1.3

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

103

4.87

21.24

1.7

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

143

4.19

20.77

1.6

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

140

4.20

20.50

1.7

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

137

612

2.46

18.84

1.3

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

138

625

2.43

18.39

1.3

1.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

108

447

2.61

17.37

1.8

1.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

124

4.03

16.82

2.9

2.0

2221.45

53.38

u/ml

0.53

(3036481) Cortisol [Moles/volume] in Serum or Plasma

128

588

2.37

16.45

3.8

1.6

394.62

360.38

nmol/l

1.05

120

532

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

141

3.78

16.27

1.3

1.6

—

(3000494) Fungus identified in Specimen by Culture

171

890

2.14

16.26

1.7

1.4

—

(3000991) Gas panel - Venous blood

131

614

2.33

16.07

9.0

8.0

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

130

609

2.33

15.96

3.0

2.3

67.51

64.58

ml/min/173m2

0.29

219

(46235355) HIV 1 and 2 tests - Meaningful Use set

156

789

2.19

15.93

1.4

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

4.44

15.60

1.8

1.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

367

2.65

15.39

11.5

10.4

25.32

24.39

mmol/l

1.97

360

(3045142) Bone marrow Pathology biopsy report

5.89

15.00

1.3

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

130

637

2.22

14.28

9.0

7.2

1.18

1.44

mmol/l

3.49

125

624

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

4.29

14.25

1.6

1.5

—

(3017181) Myelocytes/100 leukocytes in Blood

109

498

2.35

14.12

5.1

4.1

1.28

0.71

1.10

131

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

192

1095

1.96

14.04

2.2

1.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

107

487

2.36

13.97

5.1

3.3

1.24

1.22

mmol/l

1.08

101

407

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

135

678

2.17

13.93

4.2

3.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

4.13

13.92

1.6

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

4.13

13.92

1.6

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

109

3.89

13.83

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

634

5160

1.80

13.68

5.2

3.5

14.56

14.87

pmol/l

2.26

602

4647

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

806

7118

2.42

13.66

26.1

12.7

25.69

24.40

mg/l

0.51

743

5491

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

4.76

13.61

1.6

1.7

—

(3021440) Promyelocytes/100 leukocytes in Blood

103

472

2.34

13.23

5.0

4.2

0.06

0.07

0.03

105

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

11.21

12.57

3.4

2.0

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

146

787

2.02

12.43

2.1

1.8

—

(3042936) Bacteria identified in Isolate by Culture

178

1030

1.91

12.33

2.1

2.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

4.02

12.09

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

183

1080

1.87

11.90

2.7

2.8

1.46

1.64

e6/l

0.17

105

592

(3002179) Metamyelocytes/100 leukocytes in Blood

455

2.27

11.78

4.5

4.0

0.73

0.55

0.43

110

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

143

784

1.98

11.57

2.0

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

3.79

11.49

1.5

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

4.22

11.40

1.4

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

4.22

11.40

1.4

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

4.08

11.28

1.2

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

3.86

11.11

1.5

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

348

2.39

11.07

1.2

135.35

143.98

iu/ml

0.05

141

(3018095) Leukocytes [#/volume] in Urine

330

2344

1.65

11.04

3.6

3.4

132.10

115.74

e6/l

0.08

237

1689

(3030467) Casts [#/volume] in Urine by Automated count

273

1849

1.69

10.96

3.2

2.9

0.32

0.39

e6/l

0.49

212

1409

(3025159) Blasts/100 leukocytes in Blood

457

2.21

10.85

5.2

4.2

0.08

0.02

0.45

(3002582) Erythrocytes [#/volume] in Urine

292

2024

1.66

10.68

3.3

3.0

59.57

96.15

e6/l

0.33

227

1565

(40765096) Chromosome analysis panel by Banding

14.41

10.51

1.2

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

8.33

10.36

1.1

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

4.10

10.29

3.1

1.8

139.91

37.43

u/ml

0.70

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

188

1177

1.76

9.91

2.6

1.04

e6/l

0.00

110

685

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

111

3.34

9.81

3.6

3.4

62.08

58.49

0.75

111

(3010503) CD19 cells [#/volume] in Blood

7.49

9.74

2.0

2.2

1.03

0.17

e9/l

0.41

(3027945) Reticulocytes/100 erythrocytes in Blood

144

836

1.86

9.73

3.2

1.9

1.73

1.77

0.17

128

740

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

13.55

9.69

1.4

3.8

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

145

848

1.85

9.57

10.7

7.8

5.28

5.14

kpa

1.09

135

815

(3027801) Oxygen [Partial pressure] in Arterial blood

145

848

1.85

9.57

10.6

7.8

12.81

11.50

kpa

2.55

137

817

(3000012) Reticulocyte production index

3.57

9.41

2.1

2.0

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

125

3.13

9.34

5.8

5.2

598.00

540.71

iu/ml

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

7.39

9.25

2.0

3.0

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

7.39

9.25

2.9

1.8

2.98

3.30

nmol/l

0.14

(3003396) Base excess in Arterial blood by calculation

143

847

1.82

9.04

10.6

7.8

1.54

1.29

mmol/l

0.40

125

673

(3009214) Lutropin [Units/volume] in Serum or Plasma

144

2.94

9.01

1.4

10.67

6.28

u/l

1.45

120

(3026782) Osmolality of Urine

202

1325

1.68

8.90

3.2

2.6

537.02

552.96

mosm/kgh2o

0.46

172

1118

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

4.55

8.87

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

432

2.10

8.79

1.5

1.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

109

3.20

8.72

3.3

3.2

4.63

4.42

e9/l

0.11

109

(40768800) Prostate Pathology biopsy report

4.23

8.49

1.2

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

106

582

1.93

8.46

3.4

2.4

43.48

41.62

u/l

0.06

488

(3003181) Sodium [Moles/volume] in Urine

122

3.03

8.43

1.8

1.3

56.37

65.07

mmol/l

0.47

(36304419) Bacteria [Presence] in Urine

254

1798

1.58

8.14

3.2

2.8

—

(3002385) Erythrocyte distribution width [Ratio]

693

6095

1.62

8.07

30.1

15.0

14.83

15.11

0.71

687

5974

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

765

6906

1.77

8.03

23.9

11.6

81.84

78.97

ml/min/173m2

4.07

682

5614

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

412

2.06

8.01

1.7

1.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

296

2175

1.54

8.01

4.1

2.8

68.69

44.09

u/l

0.34

286

2061

(3020779) Urea [Moles/volume] in Serum or Plasma

115

665

1.84

7.82

5.5

7.4

7.56

10.26

mmol/l

4.94

110

628

(3016502) Oxygen saturation in Arterial blood

128

768

1.78

7.70

10.7

8.0

95.61

95.18

0.23

123

742

(3031040) Bacteria [#/volume] in Urine by Automated count

521

4332

1.49

7.62

4.1

3.9

169.13

1785.27

e6/l

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

3.72

7.50

1.7

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

3.96

7.46

1.4

1.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

460

1.96

7.41

3.5

2.1

9.26

11.04

g/l

3.05

422

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

+∞

7.30

7.6

0.0

0.18

—

umol/l

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

4.35

7.24

2.0

1.5

547.17

725.81

e6/l

0.98

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

4.54

7.20

1.5

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

3.99

7.19

1.9

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

3.99

7.19

1.8

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

3.99

7.19

1.8

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

3.50

7.16

1.7

1.3

—

(3016228) CD19 cells/100 cells in Blood

8.01

7.12

1.5

2.8

9.40

7.58

0.12

(21494814) CD8 cells/100 lymphocytes in Specimen

8.01

7.12

1.5

2.8

—

(40768806) Pleura Pathology biopsy report

4.11

7.10

1.4

—

(3013707) Erythrocyte sedimentation rate by Westergren method

611

5289

1.50

7.01

4.5

3.9

14.28

11.41

mm/h

4.55

567

4857

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

3.94

6.73

1.8

1.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

819

7626

1.94

6.71

27.8

15.4

138.88

139.80

mmol/l

15.39

805

7424

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

3.77

6.66

2.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

718

6473

1.57

6.43

6.1

4.2

2.76

2.17

mu/l

1.83

679

5882

(3023103) Potassium [Moles/volume] in Serum or Plasma

819

7653

1.89

6.23

28.2

15.5

3.96

4.00

mmol/l

4.65

804

7442

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

3.64

6.06

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

6.75

6.05

3.9

1.9

—

(3044889) 12 lead EKG panel

603

5290

1.43

5.80

4.2

4.0

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

316

2477

1.43

5.79

3.3

3.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

127

2.58

5.67

1.3

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

184

2.29

5.59

1.7

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

5.07

5.58

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

5.07

5.58

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

252

2.09

5.50

1.9

3.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

380

1.88

5.48

12.7

10.8

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

685

7404

0.67

5.46

4.2

4.7

1.43

1.39

mmol/l

1.25

620

6870

(3020682) Albumin/Creatinine [Ratio] in Urine

199

2655

0.68

5.46

3.5

3.9

7.33

8.05

mg/mmol

0.15

116

1736

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

136

908

1.59

5.42

2.1

2.6

22.22

24.13

0.62

121

775

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

113

2.62

5.34

1.3

1.4

95.00

106.41

u/ml

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

541

4694

1.39

5.28

3.5

3.1

61.17

51.05

u/l

1.47

507

4346

(3012516) Albumin [Mass/volume] in Urine

189

2533

0.68

5.27

2.8

3.3

52.01

173.06

mg/l

1.48

116

1664

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

3.68

5.22

3.1

2.4

37.70

46.03

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

222

1667

1.44

5.04

2.1

2.2

2.94

mg/l

0.01

187

1410

(3048929) Epstein Barr virus Ab [Presence] in Serum

173

2.25

5.04

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

275

2147

1.41

5.02

3.3

2.4

51.72

60.75

u/l

2.48

257

1976

(3023520) Reticulocytes [#/volume] in Blood

626

1.65

4.92

3.8

2.0

69.10

70.74

e9/l

0.17

479

(3008757) Leukocyte morphology finding [Identifier] in Blood

3.45

4.76

5.8

3.7

—

(4281824) Cell count and differential, peritoneal fluid

4.72

4.69

1.3

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

664

7176

0.70

4.68

3.9

4.3

1.30

1.35

mmol/l

0.88

596

6599

(3026008) Bacteria identified in Urine by Culture

232

1777

1.41

4.68

3.2

3.0

—

(3009508) Creatinine [Moles/volume] in Urine

199

2595

0.70

4.66

2.8

3.2

8.17

8.15

mmol/l

0.02

159

2197

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

697

7464

0.69

4.58

4.2

4.8

4.63

4.54

mmol/l

1.29

637

6953

(3004789) Transferrin [Mass/volume] in Serum or Plasma

139

973

1.51

4.47

2.0

2.5

2.25

2.30

g/l

0.36

131

906

(3042631) Mycobacterium sp identified in Specimen

2.66

4.42

2.3

2.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

319

1.84

4.35

3.6

3.3

4.09

4.55

pmol/l

2.55

274

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

3.08

4.26

2.8

2.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

655

7069

0.72

4.25

5.3

6.2

39.28

40.58

mmol/mol

3.22

601

6565

(3021447) Carbon dioxide [Partial pressure] in Venous blood

109

733

1.56

4.21

3.7

3.2

6.15

5.88

kpa

1.50

104

709

(3012441) Differential panel - Pleural fluid

2.94

4.19

1.2

1.4

—

(3000850) Epithelial cells [#/volume] in Urine

186

1401

1.41

4.08

2.7

2.3

4.75

4.90

e6/l

0.04

165

1260

(3025941) Bacteria identified in Stool by Culture

326

1.80

4.07

1.4

1.3

—

(3013512) EKG study

274

2206

1.35

3.99

5.3

3.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

192

1462

1.40

3.95

4.2

4.0

575.72

562.46

ng/l

0.01

163

1210

(3002032) Base excess in Venous blood by calculation

108

736

1.53

3.94

3.7

3.3

3.07

2.09

mmol/l

1.76

620

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

317

1.78

3.84

2.1

1.5

1.60

1.49

g/l

0.44

278

(3022948) Iron [Moles/volume] in Serum or Plasma

146

1064

1.45

3.83

2.2

2.5

11.94

13.67

umol/l

1.99

135

984

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

202

1.97

3.78

2.7

0.35

0.33

u/ml

0.18

113

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

168

2.06

3.74

1.6

2.2

203.35

197.77

0.12

158

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

148

2.13

3.72

1.2

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

148

2.13

3.72

1.2

1.4

—

(40768793) Breast Pathology biopsy report

4.18

3.71

1.2

1.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

532

4734

1.31

3.71

4.1

3.9

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

190

1.99

3.68

1.4

2.0

84.43

87.70

0.37

185

(40761511) CBC panel - Blood by Automated count

793

7512

1.52

3.64

21.2

12.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

177

2.02

3.63

1.5

1.4

264.67

304.17

ug/g

0.46

107

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

308

1.77

3.62

8.0

5.2

1.72

0.01

295

(3016650) Hepatitis A virus Ab [Presence] in Serum

111

2.29

3.57

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

5.34

3.51

1.1

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

6.20

3.50

1.3

1.0

154.13

69.31

nmol/24h

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

305

1.75

3.45

8.1

5.2

1.00

0.87

1.13

292

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

4.11

3.40

3.0

1.3

178.82

194.89

u/l

0.49

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

721

7601

0.73

3.27

4.6

5.3

2.75

2.69

mmol/l

0.77

652

7053

(3045788) Cell count panel - Pleural fluid

2.70

3.24

1.4

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

150

2.03

3.23

2.4

1.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

317

2671

1.29

3.21

2.2

77.36

76.56

nmol/l

0.17

286

2344

(3037756) Immunofixation for Serum or Plasma

110

2.21

3.21

1.9

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

2.28

3.15

8.2

7.1

10.47

11.51

mg/l

0.55

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

780

0.59

3.14

1.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

814

7791

1.53

3.14

15.3

9.1

26.22

28.59

u/l

2.94

794

7503

(3028308) Erythrocytes [#/volume] in Pleural fluid

2.57

3.14

1.4

1.5

18987.73

123418.40

e6/l

0.65

(3028026) IgM [Mass/volume] in Serum or Plasma

377

1.63

3.12

2.1

1.3

0.93

1.15

g/l

0.84

345

(3019225) pH of Specimen

680

1.48

3.11

4.0

3.5

—

(3052851) Hemolysis interference index of Serum or Plasma

188

1.90

3.10

3.7

3.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

245

2008

1.30

3.04

3.8

2.5

2007.33

6831.36

umol/l

1.73

222

1761

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.92

3.03

2.5

2.2

—

(3051611) Lipemic interference index of Serum or Plasma

2.66

2.97

4.0

3.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

186

1484

1.32

2.78

1.7

1.6

1.51

1.20

mg/l

0.90

147

1138

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

3.94

2.78

1.9

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

3.94

2.78

1.9

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

606

1.46

2.71

3.1

2.7

4.74

4.54

kpa

0.28

585

(21494434) Karyotype in Bone marrow

2.53

2.71

1.1

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

4.24

2.68

1.6

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

4.24

2.68

2.0

1.1

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

4.24

2.68

3.0

1.3

106.00

70.74

nmol/l

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

4.24

2.68

2.0

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.24

2.68

2.0

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

2.35

2.66

1.4

1.5

3142.40

2180.65

e6/l

—

(3051651) Icteric interference index of Serum or Plasma

3.17

2.65

5.0

4.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

7.18

2.55

1.0

2.00

1.83

umol/l

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

180

1.81

2.50

1.5

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

130

1.95

2.47

1.7

2.0

8.30

4.59

iu/l

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

2.69

2.46

1.5

1.2

25.78

37.22

u/l

0.77

(40761536) Microorganisms panel - Urine sediment

520

1.46

2.39

4.1

3.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

6.28

2.37

1.2

1.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

2.33

2.32

1.3

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

105

2.02

2.32

1.1

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.24

2.31

1.2

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.91

2.25

3.0

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

144

1147

1.30

2.18

1.8

1.3

2.35

2.78

g/l

1.90

688

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

3.02

2.15

1.0

1.1

—

(3012501) Base excess in Blood by calculation

130

1.87

2.14

5.0

2.94

2.96

mmol/l

0.01

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

432

3900

1.21

2.12

2.7

2.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

146

1.80

2.08

5.6

1.3

—

(40768797) Stomach Pathology biopsy report

122

956

1.32

2.08

1.3

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

417

1.47

2.08

1.3

—

(3019150) Specific gravity of Urine by Refractometry

125

1565

0.77

2.05

4.4

3.8

1.02

kg/l

0.02

217

(3014765) Yersinia sp identified in Stool by Organism specific culture

186

1.69

2.00

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

186

1.69

2.00

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

4.56

1.94

2.6

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.77

1.93

2.0

1.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

2.26

1.91

1.5

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

158

1.73

1.91

1.1

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

189

1.66

1.89

1.2

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.20

1.88

3.0

4.5

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

3.20

1.88

3.7

1.1

25.43

27.91

umol/l

—

(40768443) Skin Pathology biopsy report

253

1.57

1.87

1.1

1.2

—

(3048879) Bone marrow aspiration report

4.18

1.82

2.8

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.18

1.82

2.0

1.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

303

2683

1.20

1.75

2.6

2.7

210.78

149.77

ug/l

2.39

278

2466

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

132

1.76

1.75

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

467

1.40

1.74

4.1

1.4

—

(3019060) Gas panel - Arterial blood

502

1.38

1.73

5.6

5.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

171

1.66

1.72

4.6

3.3

33.05

39.83

umol/l

0.60

156

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.59

1.66

2.3

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.81

1.65

1.4

1.3

—

(3036180) Methadone [Presence] in Urine

3.01

1.58

1.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

206

0.48

1.54

1.4

1.7

5887.60

16399.94

e6/l

—

145

(3035933) Granulocytes/100 leukocytes in Blood

3.35

1.52

1.0

1.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.35

1.52

2.6

1.9

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

3.35

1.52

1.2

13.64

14.31

pmol/l

—

(3021788) Differential panel - Synovial fluid

144

0.41

1.52

1.0

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

123

1.72

1.52

1.2

286.00

277.60

u/ml

0.06

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.60

1.51

2.4

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.60

1.51

2.4

2.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.60

1.51

2.4

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

111

899

1.27

1.51

1.7

1.9

1.93

1.59

1.32

774

(3021960) Folate [Moles/volume] in Serum or Plasma

204

1765

1.20

1.50

1.6

1.5

20.97

20.67

nmol/l

0.10

174

1490

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1.91

1.50

2.1

1.4

—

nmol/l

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

490

1.35

1.49

2.7

4.1

100.68

94.36

ng/l

0.16

440

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

983

0.76

1.48

4.6

4.8

33.31

31.49

0.73

670

(4034850) Laboratory test

292

0.57

1.48

5.2

9.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

171

1.60

1.47

6.0

4.1

—

(3051593) INR in Capillary blood by Coagulation assay

2.38

1.46

9.7

14.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

825

8054

1.34

1.45

35.7

18.7

39.05

41.06

20.13

795

7458

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

179

2072

0.83

1.45

1.6

1.7

1.41

1.42

mmol/l

0.05

155

1717

(3024869) Neuronal Ab [Presence] in Serum

3.14

1.44

1.0

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2.74

1.43

1.0

1.6

—

(3010813) Leukocytes [#/volume] in Blood

825

8057

1.33

1.42

35.4

18.6

6.53

6.72

e9/l

1.23

810

7807

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1097

0.78

1.42

1.2

3.30

10.96

u/ml

2.10

423

(3024731) MCV [Entitic volume]

825

8059

1.33

1.40

35.3

18.6

91.86

91.38

2.37

818

7925

(3007461) Platelets [#/volume] in Blood

825

8059

1.33

1.40

35.5

18.6

243.22

240.80

e9/l

0.42

812

7835

(40768441) Liver Pathology biopsy report

2.42

1.39

1.3

1.5

—

(3006462) Nitrate [Presence] in Urine

2.42

1.39

2.3

3.2

—

(3035941) MCH [Entitic mass]

825

8061

1.33

1.38

35.2

18.5

30.60

30.54

0.37

818

7927

(3026361) Erythrocytes [#/volume] in Blood

825

8061

1.33

1.38

35.4

18.6

4.31

4.59

e12/l

35.34

810

7808

(3017732) Neutrophils [#/volume] in Blood

479

1.34

1.38

2.6

3.3

5.83

5.74

e9/l

0.02

383

(3000963) Hemoglobin [Mass/volume] in Blood

825

8063

1.32

1.36

35.6

18.7

130.07

139.38

g/l

45.68

818

7928

(3024928) Oxygen saturation in Venous blood

175

1.56

1.35

2.0

2.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

266

1.45

1.34

2.2

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.86

1.30

3.9

4.9

—

(40767503) Oxygen content in Capillary blood by calculation

145

1.60

1.30

3.0

2.6

14.30

16.59

1.01

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

2.79

1.28

1.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

2.79

1.28

2.6

3.4

—

(3000330) Specific gravity of Urine by Test strip

354

1.38

1.28

4.5

3.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.06

1.27

1.0

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

2.06

1.27

1.7

1.6

13.44

17.32

nmol/l

—

(3006653) Thiamine [Moles/volume] in Blood

2.06

1.27

1.3

96.11

148.95

nmol/l

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1145

0.80

1.26

1.3

21.90

35.82

iu/ml

1.19

357

(3004451) EKG impression Narrative

2.01

1.23

1.6

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

2.01

1.23

3.7

2.9

—

(3033799) Differential panel - Peritoneal fluid

2.64

1.21

2.0

2.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1.81

1.21

2.1

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

141

0.49

1.21

1.6

1.3

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1.89

1.18

1.2

1.4

439.25

63.13

pmol/l

0.77

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

240

1.43

1.17

1.9

1.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

199

1.47

1.15

6.6

1.4

43.41

46.41

mg/l

0.13

157

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1.74

1.15

2.1

1.4

0.53

0.68

nmol/l

1.24

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

200

1.47

1.13

6.6

1.4

30.18

34.56

mg/l

0.19

159

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

434

0.70

1.13

1.2

1.3

—

49.76

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.27

1.10

2.4

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

2.27

1.10

1.0

1.1

—

(36660697) Celiac disease serology panel - Serum

471

1.29

1.09

1.2

—

(3035880) pH of Pleural fluid

1.96

1.09

1.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.96

1.09

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.96

1.09

1.0

—

(1761868) Lipid panel - Serum or Plasma

242

2670

0.87

1.06

2.8

3.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

509

1.28

1.06

4.1

2.9

125.08

132.27

g/l

1.62

495

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.07

1.03

1.7

3.0

872.71

1097.62

u/ml

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1.70

1.02

1.1

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

275

1.36

0.99

1.4

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.95

0.97

1.0

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1.75

0.96

2.2

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

140

1597

0.85

0.96

1.5

1.7

467.10

39880031.53

pmol/l

1.90

114

1329

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1013

0.82

0.96

9.2

6.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.77

0.94

1.1

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

101

1.59

0.94

3.9

—

(3014051) Protein [Presence] in Urine by Test strip

175

1.44

0.93

2.6

2.2

—

(3025130) Human papilloma virus identified in Specimen

2.23

0.93

1.8

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1.72

0.93

2.2

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1.72

0.93

2.2

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

712

1.21

0.92

2.0

2.3

13.66

14.73

nmol/l

0.76

639

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

330

3065

1.12

0.91

2.1

2.0

92.11

93.21

pmol/l

0.18

169

1640

(3028626) Oxygen [Partial pressure] in Capillary blood

169

1.43

0.88

3.1

2.9

7.48

8.08

kpa

1.07

164

(3003338) MCHC [Mass/volume]

634

6117

1.13

0.88

30.2

16.8

332.57

333.68

g/l

2.39

625

6076

(3010375) cycloSPORINE [Mass/volume] in Blood

2.01

0.87

25.5

22.8

121.33

134.59

ug/l

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1.68

0.85

2.2

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1.68

0.85

2.2

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1.68

0.85

2.2

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

215

0.65

0.85

1.2

1.4

—

(3047181) Lactate [Moles/volume] in Blood

231

1.35

0.84

9.7

6.7

1.12

1.34

mmol/l

1.03

205

(3044941) Cell count panel - Synovial fluid

138

0.58

0.83

1.3

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

138

1.46

0.82

1.7

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

122

1.49

0.80

1.1

1.6

—

(3028707) Methadone [Presence] in Urine by Screen method

1.73

0.80

2.2

1.6

—

(3022689) Creatine [Moles/volume] in Urine

0.00

0.79

0.0

1.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.82

0.79

1.2

1.4

5.28

5.91

ug/l

—

(3036670) Protein [Mass/volume] in Synovial fluid

0.00

0.79

0.0

1.1

—

33.61

—

(40761535) Cells panel - Urine sediment

637

0.80

0.79

3.6

3.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.67

0.79

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.67

0.79

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.67

0.79

1.3

1.1

—

(21494755) Public health laboratory ask at order entry panel

604

0.80

0.78

1.2

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.52

0.78

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.52

0.78

1.0

1.1

—

(1616796) Gas panel - Central venous blood

148

1.43

0.78

5.1

4.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.50

0.78

1.0

1.5

168.12

176.95

pmol/l

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

140

1.44

0.77

1.3

1.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

1.70

0.76

2.4

1.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

315

2949

1.11

0.73

4.6

3.8

203.81

75.84

ng/l

0.34

258

2130

(3022145) Colonoscopy Study observation

674

1.19

0.73

1.4

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

106

0.56

0.73

1.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

373

1.25

0.70

2.2

2.4

—

(3028271) Lactate [Moles/volume] in Capillary blood

101

1.49

0.70

2.1

2.0

1.41

1.71

mmol/l

1.03

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

110

1.46

0.68

1.2

1.4

—

(3008898) HLA-B27 [Presence]

192

0.67

0.68

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

1.86

0.68

1.0

1.1

17.60

16.95

u/l

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

303

3220

0.91

0.66

3.7

3.5

21.21

23.61

2.02

131

1421

(3005570) Glucose [Moles/volume] in Urine

1.58

0.65

1.4

1.6

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

1.58

0.65

1.7

1.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

235

0.72

0.64

2.1

2.2

111.84

115.07

ug/min

0.02

145

(3039443) Prostate specific Ag panel - Serum or Plasma

269

0.74

0.64

1.7

1.6

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

379

1.23

0.63

5.3

3.3

45.59

49.72

0.53

373

(3008037) Lactate [Moles/volume] in Venous blood

173

1.34

0.62

5.9

2.8

1.45

1.52

mmol/l

0.18

168

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

382

4008

0.92

0.62

4.2

3.7

2.18

1.85

ug/l

1.43

337

3619

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

1.67

0.61

1.0

1.1

107.60

73.40

u/l

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

245

2620

0.91

0.61

4.5

3.5

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.57

0.60

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.57

0.60

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.57

0.60

1.3

1.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

255

2385

1.10

0.60

2.4

2.2

244.63

254.76

u/l

0.04

241

2237

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

232

0.73

0.60

2.1

1.8

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.00

0.60

0.0

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

1.51

0.60

1.2

1.5

225.75

388.06

pmol/l

1.42

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.54

0.59

1.1

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.51

0.58

1.6

1.5

83.75

88.26

umol/l

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.47

0.58

1.2

1.3

—

(3049717) Cytology report of Urine Cyto stain

265

1.25

0.57

2.8

1.8

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

124

1.38

0.56

1.2

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1.54

0.55

1.0

—

(3019309) Folate [Moles/volume] in Red Blood Cells

153

1401

1.11

0.55

1.8

1.7

1126.00

1138.29

nmol/l

0.05

105

1074

(3021901) Oxygen saturation in Capillary blood

142

1.35

0.54

3.5

2.7

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

205

0.73

0.54

1.4

1.2

—

6.74

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

268

1.24

0.53

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

117

1.37

0.52

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

0.62

0.52

1.0

1.1

—

21.00

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

347

0.80

0.51

1.4

1.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

398

1.19

0.51

4.8

2.9

27.05

25.21

mmol/l

2.59

385

(3013139) Helicobacter pylori Ag [Presence] in Stool

454

1.18

0.51

1.2

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

389

0.82

0.50

1.4

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.56

0.49

1.4

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

771

0.87

0.48

2.5

8.64

8.94

ug/l

0.05

689

(3020876) Protein [Mass/time] in 24 hour Urine

1.45

0.48

2.2

1.9

0.53

2.55

g/24h

—

(3022621) pH of Urine by Test strip

448

1.17

0.48

3.1

2.8

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.46

0.47

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

627

0.87

0.43

1.8

1.9

—

(3023410) Appearance of Cerebral spinal fluid

1.42

0.43

1.5

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

173

0.75

0.42

1.1

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

249

1.21

0.42

2.7

1.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

423

0.84

0.41

1.3

1.5

—

(3037121) Protein [Mass/volume] in Urine

231

1.22

0.41

3.4

2.8

0.25

g/l

0.01

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.6

—

14.43

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

0.00

0.41

0.0

1.3

—

0.66

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.41

0.0

7.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.41

0.0

1.9

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

0.00

0.41

0.0

2.0

—

9.43

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.3

—

0.44

—

(3019832) Treponema pallidum Ab [Presence] in Serum

287

1.19

0.40

1.3

1.6

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

8.88

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.40

0.0

1.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

0.00

0.40

0.0

2.9

—

55.92

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.47

0.40

4.2

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.47

0.40

4.2

1.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.34

0.40

1.9

1.3

1.01

0.99

g/l

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.43

0.39

1.8

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.39

0.0

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.34

0.36

4.9

2.4

—

(1002224) Polysomnography panel

308

0.84

0.34

1.1

—

(3044927) Protein electrophoresis panel - Urine

0.67

0.33

1.0

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.67

0.33

1.0

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

504

1.12

0.31

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

348

3369

1.05

0.31

5.4

4.6

0.00

estimate

-0.00

561

(3011397) Hemoglobin [Presence] in Urine by Test strip

173

1642

1.07

0.30

3.4

—

(3048689) Calprotectin [Mass/mass] in Stool

688

1.10

0.30

1.7

2.4

136.13

191.60

ug/g

1.12

557

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

1.34

0.30

1.0

1.3

—

(3035285) Chloride [Moles/volume] in Venous blood

1.29

0.30

4.9

2.4

107.17

105.29

mmol/l

1.14

(3041354) Potassium [Moles/volume] in Venous blood

1.29

0.30

4.9

2.4

3.99

4.10

mmol/l

1.00

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

174

0.80

0.30

1.0

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

324

0.86

0.29

1.4

1.9

47.29

40.08

nmol/l

0.60

308

(3009261) Glucose [Presence] in Urine by Test strip

351

3407

1.05

0.28

4.0

3.4

0.00

0.01

estimate

0.50

534

(3011648) Oxygen content in Venous blood

1.23

0.27

1.5

2.0

12.01

11.06

—

(3003327) Ova and parasites identified in Stool by Light microscopy

187

1.18

0.27

1.3

1.7

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

104

1.25

0.26

1.0

1.1

1.56

1.52

g/l

0.20

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

124

1312

0.94

0.26

1.2

1.18

1.93

u/ml

0.61

370

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.68

0.26

1.0

1.1

—

(3045414) Leukocytes [Presence] in Urine

293

1.13

0.24

2.1

1.8

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

0.73

0.24

1.0

1.2

7.80

7.66

mmol/l

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

476

1.10

0.23

3.9

3.5

2.87

1.99

mmol/l

0.80

351

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

147

0.81

0.23

1.2

47.19

17.77

u/l

0.84

129

(3044242) Glucose [Moles/volume] in Arterial blood

1.32

0.23

3.4

1.9

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.25

0.22

1.8

1.4

—

(3009343) pH of Capillary blood

497

1.09

0.22

4.0

3.5

7.39

7.41

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

662

1.08

0.22

2.5

3.1

247.29

212.70

ng/l

0.25

613

(3017569) Oxygen content in Arterial blood

1.22

0.22

1.8

2.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.22

0.22

1.0

1.1

—

(3022313) Gas panel - Capillary blood

363

1.11

0.21

4.0

3.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.21

0.0

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

2.39

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.2

—

192.55

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.21

0.0

1.6

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.21

0.0

1.5

—

(3009015) Lactate [Moles/volume] in Synovial fluid

0.00

0.21

0.0

1.2

—

7.16

—

(3016330) Potassium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.21

0.0

1.0

—

(3035350) Ketones [Presence] in Urine by Test strip

346

3378

1.04

0.21

3.9

3.4

0.00

estimate

0.50

604

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.8

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.21

0.0

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.21

0.0

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.21

0.0

1.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.21

0.0

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

0.21

0.0

1.6

—

(4200892) Spirometry reversibility

567

1.08

0.20

1.3

1.4

—

(3015736) pH of Urine

281

2734

1.04

0.20

3.4

3.2

6.18

5.86

0.70

191

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.20

0.0

4.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

114

0.79

0.20

1.4

1.5

—

(4094501) Cardiovascular stress test using bicycle ergometer

239

0.88

0.19

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

165

1.15

0.19

4.2

3.2

26.63

25.68

mg/l

0.09

109

(3041096) Erythrocytes [Presence] in Urine by Automated

182

1758

1.04

0.19

4.0

3.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

224

1.12

0.17

1.8

1.6

—

(4062490) Immunoglobulin typing, IgG

1.13

0.16

1.0

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

168

1.13

0.15

2.4

2.2

118.29

133.85

g/l

1.35

122

(3000764) Benzodiazepines [Presence] in Urine

130

1.16

0.15

1.8

1.5

—

(3027944) Amphetamines [Presence] in Urine

130

1.16

0.15

1.8

1.5

—

(3011288) Drugs identified in Urine by Screen method

1.13

0.15

2.6

1.9

—

(3023419) Bacteria identified in Sputum by Culture

140

1.15

0.15

2.6

2.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

192

0.88

0.15

2.1

1.5

0.29

0.23

g/l

0.91

184

(3024980) IgG subclass 4 [Mass/volume] in Serum

103

1.17

0.13

1.1

1.6

0.66

0.94

g/l

—

(3004616) Nuclear Ab [Presence] in Serum

0.81

0.13

1.6

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

170

1.12

0.13

1.3

1.2

3.08

54.31

e6/l

0.85

134

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

170

1.12

0.13

1.3

131.25

794.35

e6/l

0.52

139

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

109

0.82

0.13

1.6

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

171

1.11

0.12

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

152

1.12

0.12

1.3

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

225

2297

0.97

0.12

2.9

2.6

0.71

0.69

ug/l

0.19

156

1460

(3027008) Opiates [Presence] in Urine

133

1.13

0.12

1.8

1.5

—

(3028300) Cannabinoids [Presence] in Urine

133

1.13

0.12

1.8

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

105

1.14

0.11

1.4

2.0

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

232

2277

1.03

0.11

3.3

3.1

1363.69

1386.35

ng/l

0.02

205

1931

(3016879) Cocaine [Presence] in Urine

126

1.11

0.09

1.9

1.5

—

(3020891) Body temperature

327

0.95

0.07

4.4

4.8

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

163

0.92

0.07

1.4

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

102

0.88

0.06

1.0

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

889

1.03

0.06

1.4

1.3

466.67

507.41

titre

0.13

216

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

202

0.94

0.05

1.5

1.7

—

(3000492) Spirometry study

688

1.02

0.03

1.4

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

102

1.08

0.03

1.6

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1.06

0.01

1.0

1.1

109.40

113.60

—

(3020961) Endomysium IgA Ab [Titer] in Serum

246

0.97

0.00

1.0

1.1

—

264.43

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

324

1.02

0.00

1.2

1.7

—

37.74

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

184

0.98

0.00

1.4

1.2

1.92

2.82

u/ml

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

196

1.02

0.00

2.0

1.5

1.22

1.14

g/l

0.54

186

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

266

1.02

0.00

1.9

1.6

—

306.25

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

268

1.01

0.00

7.0

1.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

732

7317

1.00

0.00

4.4

4.8

5.93

6.08

mmol/l

2.74

686

6674

(3029937) Albumin [Presence] in Urine by Test strip

182

1817

1.00

0.00

4.3

3.7

0.00

0.01

estimate

0.50

536

(3045424) Erythrocytes [Presence] in Urine

103

0.97

0.00

1.9

1.5

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.1

—

12.54

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

0.99

0.00

1.3

2.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.0

1.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.0

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.5

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

-0.00

0.0

1.6

—

7.61

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.94

-0.00

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

-0.00

0.0

1.0

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

-0.00

0.0

6.8

—

13.40

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

-0.00

0.0

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.8

—

398.17

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.00

-0.00

0.0

2.4

—

0.38

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

-0.00

0.0

10.2

—

(3016018) Differential panel - Cerebral spinal fluid

0.92

-0.00

1.4

1.3

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

-0.00

0.0

1.4

—

(4146454) Self-monitoring of blood glucose

0.93

-0.00

2.3

2.7

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.94

-0.00

1.0

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.94

-0.00

1.0

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

1.00

-0.00

2.0

2.2

—

(3042517) Benzodiazepines panel - Urine

0.00

-0.00

0.0

1.0

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

-0.00

0.0

12.4

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

-0.00

0.0

1.6

—

2.00

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

59.68

—

(3051339) Copper [Moles/volume] in Blood

0.00

-0.00

0.0

1.0

—

16.04

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

2.2

—

1.32

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1.00

-0.00

1.8

1.3

1.66

1.50

g/l

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.94

-0.00

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_TONSIL_BASEOFTONGUE_WIDE – Malignant cancer of tonsil and base of tongue, including Hilmo

GWS hits: 1

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant cancer of tonsil and base of tongue, including Hilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant cancer of tonsil and base of tongue, including Hilmo (C3_TONSIL_BASEOFTONGUE_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints